{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:47:08Z","timestamp":1789912028182,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejmech.2019.02.075","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T01:58:27Z","timestamp":1551664707000},"page":"89-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["4-Imidazo[2,1-b]thiazole-1,4-DHPs and neuroprotection: preliminary study in hits searching"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-8207","authenticated-orcid":false,"given":"Alberto","family":"Leoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Frosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Micucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-0968","authenticated-orcid":false,"given":"Sandro","family":"Cosconati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-9740","authenticated-orcid":false,"given":"Roberta","family":"Budriesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.02.075_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mds.21675","article-title":"The pathogenesis of cell death in Parkinson's disease","volume":"22","author":"Olanow","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2019.02.075_bib2","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington's disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2019.02.075_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuint.2007.04.026","article-title":"Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies","volume":"50","author":"Hazell","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2019.02.075_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2017.08.048","article-title":"Beyond the critical point: an overview of excitotoxicity, calcium overload and the downstream consequences","volume":"663","author":"Banoa","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.02.075_bib5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/hs1001.096009","article-title":"Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review","volume":"32","author":"Horn","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2019.02.075_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2019.02.075_bib7","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.2174\/092986711797535173","article-title":"1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far AnD perspectives. (Part 1): action in ion channels and GPCRs","volume":"18","author":"Ioan","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tips.2011.02.012","article-title":"Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting","volume":"32","author":"Zuccotti","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.02.075_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.02.075_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.07.014","article-title":"Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses","volume":"1581","author":"Daschil","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.02.075_bib11","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.2174\/092986712802884204","article-title":"1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives. (Part 2): action in other targets and antitargets","volume":"19","author":"Carosati","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib12","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1523\/JNEUROSCI.2946-16.2017","article-title":"Lower affinity of isradipine for L-type Ca(2+) channels during substantia nigra dopamine neuron-like activity: implications for neuroprotection in Parkinson's disease","volume":"37","author":"Ortner","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.02.075_bib13","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/jm070681+","article-title":"Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity","volume":"51","author":"Budriesi","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib14","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1021\/jm301839q","article-title":"Ligand based approach to L-type calcium channel by imidazo[2,1-b]thiazole-1,4-dihydropyridines: from heart activity to brain affinity","volume":"56","author":"Locatelli","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib15","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1021\/ja01180a037","article-title":"Hantzsch's pyridine synthesis","volume":"71","author":"Phillips","year":"1949","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.02.075_bib16","unstructured":"Ambinter Stock Screening Collection: Order Number: Amb3814428, CAS: 564442-65-5."},{"key":"10.1016\/j.ejmech.2019.02.075_bib17","series-title":"Imidazo[2, 1-b]thiazoles and Their Use as Pharmaceuticals","author":"Zoller","year":"2006"},{"key":"10.1016\/j.ejmech.2019.02.075_bib18","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1016\/j.ejmech.2011.07.001","article-title":"Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors","volume":"46","author":"Andreani","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib19","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1135\/cccc19912436","article-title":"5-Formylimidazo[2,1-b]thiazoles and derivatives with herbicidal activity","volume":"56","author":"Andreani","year":"1991","journal-title":"Collect. Czechoslov. Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.02.075_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ardp.19823150511","article-title":"Potential antitumor agents, VII. 5-Substituted 6-phenylimidazo[2,1-b]thiazoles","volume":"315","author":"Andreani","year":"1982","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2019.02.075_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0223-5234(96)89164-1","article-title":"Synthesis and cardiotonic activity of imidazo[2,1-b]thiazoles bearing a lactam ring","volume":"31","author":"Andreani","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib22","first-page":"203","article-title":"Potential antitumor agents. 34. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from diimidazo[1,2-a: 1,2-c] pyrimidine","volume":"24","author":"Andreani","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2019.02.075_bib23","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1021\/jm061077m","article-title":"Synthesis and antitumor activity of guanylhydrazones from 6-(2,4-dichloro-5-nitrophenyl)imidazo[2,1-b]thiazoles and 6-pyridylimidazo[2,1-b]thiazoles(1)","volume":"49","author":"Andreani","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib24","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm040888s","article-title":"Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline","volume":"48","author":"Andreani","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0223-5234(92)90159-X","article-title":"Synthesis and cardiotonic activity of 2,5-dimethoxyphenylimidazo[2,1-b]thiazoles","volume":"27","author":"Andreani","year":"1992","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib26","doi-asserted-by":"crossref","DOI":"10.1021\/jm200199r","article-title":"Cystic fibrosis: a new target for 4-Imidazo[2,1-b]thiazole-1,4-Dihydropyridines","volume":"54","author":"Budriesi","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s11064-010-0371-4","article-title":"Calcium signalling and Alzheimer's disease","volume":"36","author":"Berridge","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2019.02.075_bib28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1474-4422(07)70246-6","article-title":"Calcium, ageing, and neuronal vulnerability in Parkinson's disease","volume":"6","author":"Surmeier","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2019.02.075_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tins.2009.01.006","article-title":"Calcium homeostasis, selective vulnerability and Parkinson's disease","volume":"32","author":"Chan","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2019.02.075_bib30","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2174\/0929867321666131228204246","article-title":"Calcium ion--the key player in cerebral ischemia","volume":"21","author":"Kumar","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1242\/dmm.006841","article-title":"A\u00a0translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug","volume":"4","author":"Copenhaver","year":"2011","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.ejmech.2019.02.075_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","article-title":"Brain oedema in focal ischemia: molecular pathophysiology and theoretical implications","volume":"6","author":"Simard","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2019.02.075_bib33","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.011","article-title":"Disrupted ionic homeostasis in ischemic stroke and new therapeutic targets","volume":"26","author":"Hu","year":"2017","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejmech.2019.02.075_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijdevneu.2012.05.007","article-title":"Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal","volume":"30","author":"Lecht","year":"2012","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ejmech.2019.02.075_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuropharm.2012.05.033","article-title":"Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers","volume":"63","author":"Hashioka","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.02.075_bib36","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.02.002","article-title":"Vasopressin hypersecretion-associated brain edema formation in ischemic stroke: underlying mechanisms","volume":"6","author":"Jia","year":"2016","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejmech.2019.02.075_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1874467208666150507105845","article-title":"Pharmacology of L-type calcium channels: novel drugs for old targets?","volume":"8","author":"Striessnig","year":"2015","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.075_bib38","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.bbadis.2011.08.013","article-title":"Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine","volume":"12","author":"Anekonda","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.02.075_bib39","unstructured":"ClinicalTrials NCT02168842: Efficacy of Isradipine in Early Parkinson Disease."},{"key":"10.1016\/j.ejmech.2019.02.075_bib40","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1021\/jm500263v","article-title":"New 5-unsubstituted dihydropyridines with improved Cav1.3 selectivity as potential neuroprotective agents against ischemic injury","volume":"57","author":"Tenti","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib41","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1073\/pnas.1620052114","article-title":"Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis","volume":"16","author":"Schampel","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.02.075_bib42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/01616412.2017.1356157","article-title":"Nimodipine activates neuroprotective signaling events and inactivates autophages in the VCID rat hippocampus","volume":"10","author":"Hu","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejmech.2019.02.075_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2016.10.014","article-title":"Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats","volume":"288","author":"Gupta","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2019.02.075_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00441-014-1936-3","article-title":"The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function","volume":"357","author":"Berger","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejmech.2019.02.075_bib45","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.2157282","article-title":"The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity","volume":"247","author":"Weiss","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.02.075_bib46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/jcb.25760","article-title":"Castanea sativa mill. Bark extract protects U-373 MG cells and rat brain slices against ischemia and reperfusion injury","volume":"11","author":"Santulli","year":"2017","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jcb.25302","article-title":"Neuroprotective effects of castanea sativa mill. Bark extract in human neuroblastoma cells subjected to oxidative stress","volume":"117","author":"Brizi","year":"2016","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib48","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2019.02.075_bib49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.phrs.2012.08.003","article-title":"A\u00a0novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury","volume":"66","author":"Contartese","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2019.02.075_bib50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2006.12.030","article-title":"Neuroprotection afforded by diazepam against oxygen\/glucose deprivation-induced injury in rat cortical brain slices","volume":"561","author":"Ricci","year":"2007","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419302077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419302077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T10:39:37Z","timestamp":1565174377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419302077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":50,"alternative-id":["S0223523419302077"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.075","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Imidazo[2,1-b]thiazole-1,4-DHPs and neuroprotection: preliminary study in hits searching","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}